[
  {
    "ts": "2025-11-24T12:17:09+00:00",
    "headline": "Novo Nordisk Dives As Ozempic Fails To Slow Alzheimer's; Lilly Falls, Biogen Jumps",
    "summary": "Novo Nordisk reported Monday that a Ozempic pill failed to slow the progression of Alzheimer's in two big studies. Novo dived, Eli Lilly fell. Biogen rose.",
    "url": "https://www.investors.com/news/novo-nordisk-dives-ozempic-fails-slow-alzheimers-eli-lilly-biogen/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "a51cd60d-fe17-396c-bf06-7516a239f75c",
      "content": {
        "id": "a51cd60d-fe17-396c-bf06-7516a239f75c",
        "contentType": "STORY",
        "title": "Novo Nordisk Dives As Ozempic Fails To Slow Alzheimer's; Lilly Falls, Biogen Jumps",
        "description": "",
        "summary": "Novo Nordisk reported Monday that a Ozempic pill failed to slow the progression of Alzheimer's in two big studies. Novo dived, Eli Lilly fell. Biogen rose.",
        "pubDate": "2025-11-24T12:17:09Z",
        "displayTime": "2025-11-24T12:17:09Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a51cd60d-fe17-396c-bf06-7516a239f75c/novo-nordisk-dives-as-ozempic.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7obXGavYr8kgk3K.Mtzb2w--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jzjG937xziJt0639IwSv.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/novo-nordisk-dives-ozempic-fails-slow-alzheimers-eli-lilly-biogen/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]